InMed Pharmaceuticals, Inc.
(Toronto Stock Exchange : INM)

( )
INM PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 3.50%101.030.0%$1484.62m
BIIBBiogen, Inc. -0.32%243.381.7%$644.21m
AMGNAmgen, Inc. -0.43%222.221.3%$567.12m
GILDGilead Sciences, Inc. -0.37%59.891.0%$536.35m
VRTXVertex Pharmaceuticals, Inc. 1.24%217.871.9%$474.35m
REGNRegeneron Pharmaceuticals, Inc. 0.94%523.612.7%$454.22m
BNTXBioNTech SE 2.34%106.500.0%$445.38m
ILMNIllumina, Inc. 0.35%301.853.5%$377.50m
NVAXNovavax, Inc. 8.59%93.9892.9%$336.34m
EXASEXACT Sciences Corp. 4.61%120.5419.6%$304.90m
MGENMiragen Therapeutics, Inc. 0.35%17.300.7%$272.94m
SRRKScholar Rock Holding Corp. -1.57%41.400.0%$245.77m
APVOAptevo Therapeutics, Inc. -0.18%45.5518.3%$228.01m
SGENSeagen Inc. -3.08%168.075.8%$173.40m
ALXNAlexion Pharmaceuticals, Inc. 1.01%122.612.0%$162.56m

Company Profile

InMed Pharmaceuticals, Inc. engages in the research and development of cannabinoid-based therapies and biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. It offers pipeline of medications that target diseases with unmet medical needs, such as epidermolysis bullosa, glaucoma, and orofacial pain. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.